Do rheumatoid arthritis patients have equal access to treatment with new medicines? Tumour necrosis factor-alpha inhibitors use in four European countries

J.M. Hoebert; A.K. Mantel-Teeuwisse; L. van Dijk; J.W.J. Bijlsma; H.G.M. Leufkens

doi:10.1016/j.healthpol.2011.10.011.

Do rheumatoid arthritis patients have equal access to treatment with new medicines? Tumour necrosis factor-alpha inhibitors use in four European countries

Translated title of the contribution: Do rheumatoid arthritis patients have equal access to treatment with new medicines? Tumour necrosis factor-alpha inhibitors use in four European countries

J.M. Hoebert
, A.K. Mantel-Teeuwisse
, L. van Dijk
, J.W.J. Bijlsma
, H.G.M. Leufkens

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Do rheumatoid arthritis patients have equal access to treatment with new medicines? Tumour necrosis factor-alpha inhibitors use in four European countries
Original language	Undefined/Unknown
Pages (from-to)	76-83
Number of pages	8
Journal	Health Policy
Volume	104
Issue number	1
DOIs	https://doi.org/10.1016/j.healthpol.2011.10.011.
Publication status	Published - 2012

Keywords

Epidemiology
Farmacie(FARM)
Biomedische technologie en medicijnen
Ziekenhuisstructuur en organisatie van de gezondheidszorg
Public Health

Access to Document

10.1016/j.healthpol.2011.10.011.

Cite this

@article{eb7a4ce150aa420cb734d7757274c2fb,

title = "Do rheumatoid arthritis patients have equal access to treatment with new medicines? Tumour necrosis factor-alpha inhibitors use in four European countries",

keywords = "Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health",

author = "J.M. Hoebert and A.K. Mantel-Teeuwisse and \{van Dijk\}, L. and J.W.J. Bijlsma and H.G.M. Leufkens",

year = "2012",

doi = "10.1016/j.healthpol.2011.10.011.",

language = "Undefined/Unknown",

volume = "104",

pages = "76--83",

journal = "Health Policy",

issn = "0168-8510",

publisher = "Elsevier Ireland Ltd",

number = "1",

}

TY - JOUR

T1 - Do rheumatoid arthritis patients have equal access to treatment with new medicines? Tumour necrosis factor-alpha inhibitors use in four European countries

AU - Hoebert, J.M.

AU - Mantel-Teeuwisse, A.K.

AU - van Dijk, L.

AU - Bijlsma, J.W.J.

AU - Leufkens, H.G.M.

PY - 2012

Y1 - 2012

KW - Epidemiology

KW - Farmacie(FARM)

KW - Biomedische technologie en medicijnen

KW - Ziekenhuisstructuur en organisatie van de gezondheidszorg

KW - Public Health

U2 - 10.1016/j.healthpol.2011.10.011.

DO - 10.1016/j.healthpol.2011.10.011.

M3 - Article

SN - 0168-8510

VL - 104

SP - 76

EP - 83

JO - Health Policy

JF - Health Policy

IS - 1

ER -